The applicants should have a PhD or MD/PhD (graduated since 2020) in cell or developmental biology, biochemistry, neurobiology, or genetics, with an excellent publication record. Candidates with proven experience in chromatin architecture, membraneless organelles, RNA-binding proteins, high resolution microscopy, AAV-based therapeutics, and/or relevant new technologies will be given preference. Successful fellows will have a strong passion to conduct independent scientific research and possess excellent communication and interpersonal skills. For more information, visit https://nei.nih.gov/research/research-labs-and-branches/neurobiology-neurodegeneration-repair-laboratory and https://www.nei.nih.gov/research/research-labs-and-branches/ocular-gene-therapy-core.
Annual stipend will be commensurate with experience and training. The position provides generous scientific resources, stipend support, and health benefits. U.S. citizens, U.S. permanent residents, and non-U.S. citizens are eligible to apply.
Interested applicants should submit a cover letter with career goals, potential research projects of interest, curriculum vitae with publications, and contact information of three references to either Anand Swaroop, Ph.D., Senior Investigator and Chief, NNRL/NEI/NIH at swaroopa@nih.gov or Tiansen Li, Ph.D., Senior Investigator and Head of the Ocular Gene Therapy Core, NEI/NIH at lit4@mail.nih.gov.
The NIH is dedicated to building a diverse community in its training and employment programs. DHHS, NIH, and NEI are Equal Opportunity Employers.